SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease

Movement Disorders : Official Journal of the Movement Disorder Society
Pablo Martinez-MartinELEP Group

Abstract

This study evaluated the comparative validity and usefulness of the Parkinson's Disease Sleep Scale (PDSS) and the Scales for Outcomes in PD-Sleep Scale (SCOPA-S), two disease-specific rating scales for assessing sleep disorders in Parkinson's disease (PD). Hoehn and Yahr staging (HY), SCOPA-Motor, Mini-Mental State Examination, Clinical Impression of Severity Index for PD, Hospital Anxiety and Depression Scale, EuroQoL, and SCOPA-Psychosocial, in addition to PDSS and SCOPA-S (night-time sleep (NS) and daytime sleepiness (DS) subscales), were applied to 187 consecutive PD patients. PDSS and SCOPA-S proved similar in acceptability, scaling assumptions, precision, and internal consistency (Cronbach's alpha = 0.82-0.84). Factor analysis revealed five separate factors for PDSS (67% of the variance) and one factor for each SCOPA-S subscale (60% of the variance for NS and 57% for DS). Correlation coefficient between PDSS and SCOPA-S NS was -0.60. Sleep scales correlated moderately with mood, low-to-moderate with HRQoL, and low with the rest of measures. PDSS and SCOPA-S DS discriminated between patients grouped by HY severity levels and disease duration. Cutoff points of 82/83 for PDSS and 6/7 for SCOPA-S NS were drawn to identify PD...Continue Reading

References

Sep 1, 1979·Medical Care·M EisenR H Brook
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
Dec 1, 1988·Clinical Neuropharmacology·A J LeesV L Campbell
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Aug 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·C A McHorney, A R Tarlov
Mar 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·K KarlsenK Jørgensen
Apr 14, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·K H KarlsenJ G Maeland
Sep 3, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A M DamianoM K Willian
Dec 10, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergK Karlsen
May 12, 2000·Journal of Evaluation in Clinical Practice·K W Wyrwich, F D Wolinsky
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN Quinn
Feb 24, 2001·Medical Decision Making : an International Journal of the Society for Medical Decision Making·X BadiaP Kind
Nov 7, 2001·Acta Neurologica Scandinavica·S HappeJ Zeitlhofer
Dec 26, 2001·Journal of Clinical Epidemiology·D E BeatonJ G Wright
Jun 1, 2002·Parkinsonism & Related Disorders·L M ShulmanW J Weiner
Jun 21, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Neil AaronsonRuth E Stein
Oct 16, 2002·Neuropsychobiology·Svenja HappeUNKNOWN FAQT study investigators
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·K R ChaudhuriC Trenkwalder
Dec 7, 2002·Clinical Neuropharmacology·Johan MarinusJacobus J van Hilten
Feb 19, 2003·Journal of Clinical Epidemiology·Johan MarinusAnne M Stiggelbout
Jun 12, 2003·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·C B TerweeP M M Bossuyt
Nov 5, 2003·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·T ScaravilliF Bracco
Jan 30, 2004·Sleep·Johan MarinusAnne Margarethe Stiggelbout
Feb 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·J MarinusJ J van Hilten
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martínez-MartínK Ray Chaudhuri
Jan 12, 2005·Neurology·Christopher G GoetzSue Leurgans
May 17, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Kathleen W WyrwichUNKNOWN Clinical Significance Consensus Meeting Group
Jun 9, 2005·Journal of Clinical Epidemiology·Pablo Martínez-MartínBelén Frades
Sep 15, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martínez-MartínUNKNOWN ELEP Project Members
Jul 20, 2006·The Journal of Clinical Psychiatry·Leora L BorekJoseph H Friedman
Nov 14, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·M D GjerstadJ P Larsen
Mar 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragChristopher G Goetz
Jun 5, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martinez-MartinK Ray Chaudhuri
Jun 9, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Keisuke SuzukiKoichi Hirata
Oct 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Dagmar VerbaanJacobus J van Hilten

❮ Previous
Next ❯

Citations

Jan 18, 2013·Parkinson's Disease·Todd J Swick
Mar 1, 2011·Therapeutic Advances in Chronic Disease·Steven Wishart, Graeme J A Macphee
Aug 14, 2012·BMC Neurology·Elisabeth SvenssonBørge Sivertsen
Feb 18, 2011·CNS Drugs·Bettina KnieK Ray Chaudhuri
Apr 24, 2014·Journal of Neural Transmission·María Ascensión Zea-Sevilla, Pablo Martínez-Martín
Oct 10, 2013·Revue neurologique·T LebouvierP Derkinderen
May 21, 2016·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Peter HagellOskar Hansson
Oct 1, 2013·Journal of the Neurological Sciences·Michael K ScullinDonald L Bliwise
Mar 23, 2010·Clinical Neurology and Neurosurgery·Sharon L NaismithSimon J G Lewis
Apr 13, 2011·Sleep Medicine Reviews·Geert MayerYves Dauvilliers
Mar 26, 2015·Arquivos de neuro-psiquiatria·Vanessa Alatriste-BoothAmin Cervantes-Arriaga
Jan 25, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Aleksandar Videnovic
Dec 8, 2017·Journal of Korean Medical Science·Young Hee SungTae Beom Ahn
Jun 25, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ambra Stefani, Birgit Högl
Feb 12, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderKallol Ray Chaudhuri
Mar 7, 2017·Frontiers in Neurology·Giuseppe LoddoFederica Provini
Nov 2, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Tasneem PeeraullyEng-King Tan
Aug 14, 2018·Current Neurology and Neuroscience Reports·Michela FigorilliMonica Puligheddu
Jun 14, 2018·Frontiers in Neurology·Mónica M KurtisPablo Martinez-Martin
Oct 11, 2016·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N A AmosovaE L Gavrilov
Jun 22, 2018·BMC Neurology·Andrius RadziunasAdomas Bunevicius
Nov 23, 2017·Frontiers in Neurology·Alba AyalaPablo Martínez-Martín
Apr 16, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Simone GoebelH Maximilian Mehdorn
Apr 21, 2018·Current Neurology and Neuroscience Reports·Aleksandar Videnovic
Jul 23, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Abhimanyu MahajanNeepa Patel
Oct 13, 2020·Journal of Geriatric Psychiatry and Neurology·Diego Santos-GarcíaP Martinez-Martin
Oct 22, 2020·NPJ Parkinson's Disease·Silje BjerknesMathias Toft
Oct 23, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Anna BerardiGiovanni Galeoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Birgit HöglChristopher G Goetz
Movement Disorders : Official Journal of the Movement Disorder Society
Claudia TrenkwalderKallol Ray Chaudhuri
Movement Disorders : Official Journal of the Movement Disorder Society
Dagmar VerbaanJacobus J van Hilten
The Journal of Clinical Psychiatry
Leora L BorekJoseph H Friedman
© 2022 Meta ULC. All rights reserved